Title Chief Executive Officer & Co-Founder Company Uptake Bio Brad Keywell, 46, is the Co-Founder and CEO of Uptake Technologies, a predictive analytics platform for major industries, creating improvements in productivity, reliability, and safety through actionable insight. Brad is a Co-Founder of Tempus, a technology company that has built an operating system to battle cancer, and a Co-Founder and Managing Partner of Lightbank, a venture fund investing in technology businesses. He is a Co-Founder and Director of Groupon (NASDAQ:GRPN). He is a Co-Founder and Director of MediaOcean, an integrated technology platform for the media buying industry. He is Co-Founder and Director of Echo Global Logistics (NASDAQ:ECHO), a technology-based enterprise transportation management firm. He is a member of the Board of Trustees of Equity Residential (NYSE:EQR), an S&P 500 company. Brad is the Founder and Chairman of Chicago Ideas Week, one of the major ideas and innovation platforms in the world (and the most affordable and inclusive ideas conference) which hosts nearly 200 speakers at 80+ events with global media coverage. He is an Adjunct Professor at the University of Chicago Booth School of Business, where he teaches a course on entrepreneurship and disruptive technology. He is the Immediate Past Chairman of the Illinois Innovation Council, appointed by Illinois Governor Pat Quinn. He has served on the Mayor’s Committee on Technology Infrastructure, and the Mayor’s Chicago-China Friendship Initiative, both positions appointed by Chicago Mayor Richard M. Daley. Brad is the Chairman of the Future Founders Foundation, which runs programs designed to help teach and inspire high school students in entrepreneurship, and connect them with mentors and role models for guidance and inspiration. The Future Founders and Connect to the Future programs are at over 100 schools in the Chicagoland area, and provide real-world experiences and hands-on impact to encourage students to focus on the value of their education and expand their horizons.